The insusceptibility of the laboratory mouse for most testicular type-II germ cell tumors and their precursor stages questions the suitability of a TSPY transgenic mouse model as a tool to address TSPY putative oncogenic function in gonadal tumor formation. This evidence concerns the gene TSPY1 and testicular germ cell tumor.